Work

Final Clinical Results of a Phase 2 NCI Multicenter Study of Romidepsin in Recurrent Cutaneous T-Cell Lymphoma (Molecular Analyses Included).

Year: 2008

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v112.11.1568.1568

Authors: Susan Bates, Richard Piekarz, John Wright, Robin Frye, William Douglas Figg, Steven L. Allen, Michael Craig, Larisa Geskin, Laura Hutchins, David Joske, Mark Kirschbaum, John P. Leonard, Miles Prince, Craig B. Reeder, Maryalice Stetler- Stevenson, Alex Ling, Jean Nichols

Institutions: National Institutes of Health, National Cancer Institute, Northwell Health, North Shore University Hospital, West Virginia University Hospitals, University of Pittsburgh, University of Arkansas for Medical Sciences, Sir Charles Gairdner Hospital, City Of Hope National Medical Center, Weill Cornell Medicine, Peter MacCallum Cancer Centre, Mayo Clinic in Arizona

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2572724312

FWCI: 4.657

Cites:

Cited by: 18

Related to: 10